Literature DB >> 8740430

Lack of myoblasts migration between transplanted and host muscles of mdx and normal mice.

P D Moens1, M C Van-Schoor, G Maréchal.   

Abstract

Extensor digitorum longus muscles of normal mice (C57BL/10ScSn hereafter called C57) were orthotopically transplanted into dystrophin-deficient mice (mdx) and reciprocally, mdx Extensor digitorum longus muscles were transplanted into C57 mice. After an initial phase of degeneration, transplanted muscles regenerate nearly completely, as evaluated from the maximum isometric force of muscles isolated 60 days after the surgery. In other similar experiments, instead of isolating the grafted muscles, we excised the antero-external muscles of the leg, including the grafted muscle. Cryostat cross-sections at three levels along the muscles were immunostained with an anti-dystrophin antibody. No muscle cells of dystrophin-deficient muscles grafted into normal mice took the antibody except a few 'revertant' fibres, while all the muscle cells of the normal host were immunostained. Reciprocally, all the muscles cells of normal grafts were stained, whilst no antibody stained the cells of the surrounding muscles of the dystrophin-deficient host. These experiments show that very few if any of the myoblasts or muscle precursor cells, active during the regeneration of grafted muscle, migrate into the adjacent muscles. These results could be explained by the absence, in our work, of injuries of the grafted and adjacent host muscles epimysium and the absence of extensive inflammatory reactions. This lack of myoblast mobility suggest that when myoblast transfer is applied to muscle therapy, it will be necessary to inject myoblasts within each muscle to obtain an efficient treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740430     DOI: 10.1007/bf00140322

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  32 in total

1.  Cell and fiber-type distribution of dystrophin.

Authors:  E P Hoffman; M S Hudecki; P A Rosenberg; C M Pollina; L M Kunkel
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

2.  Beating heart muscle in a skeletal muscle bed.

Authors:  H Jockusch; G Mehrke; E M Füchtbauer
Journal:  Exp Neurol       Date:  1983-09       Impact factor: 5.330

3.  Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.

Authors:  G Karpati; Y Pouliot; E Zubrzycka-Gaarn; S Carpenter; P N Ray; R G Worton; P Holland
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts.

Authors:  J Huard; C Labrecque; G Dansereau; L Robitaille; J P Tremblay
Journal:  Muscle Nerve       Date:  1991-02       Impact factor: 3.217

5.  Somatic reversion/suppression of the mouse mdx phenotype in vivo.

Authors:  E P Hoffman; J E Morgan; S C Watkins; T A Partridge
Journal:  J Neurol Sci       Date:  1990-10       Impact factor: 3.181

6.  Difference in the expression pattern of dystrophin on the surface membrane between the skeletal and cardiac muscles of mdx carrier mice.

Authors:  H Tanaka; K Ikeya; E Ozawa
Journal:  Histochemistry       Date:  1990

7.  The origin of muscle stem cells in rat triceps surae regenerating after mincing.

Authors:  E Ghins; M Colson-van Schoor; G Maréchal
Journal:  J Muscle Res Cell Motil       Date:  1984-12       Impact factor: 2.698

8.  Cell transplantation as an experimental treatment for Duchenne muscular dystrophy.

Authors:  P K Law; T G Goodwin; Q Fang; M B Deering; V Duggirala; C Larkin; J A Florendo; D S Kirby; H J Li; M Chen
Journal:  Cell Transplant       Date:  1993 Nov-Dec       Impact factor: 4.064

9.  Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.

Authors:  P K Law; T G Goodwin; Q Fang; V Duggirala; C Larkin; J A Florendo; D S Kirby; M B Deering; H J Li; M Chen
Journal:  Cell Transplant       Date:  1992       Impact factor: 4.064

10.  Dystrophin distribution in heterozygote MDX mice.

Authors:  S C Watkins; E P Hoffman; H S Slayter; L M Kunkel
Journal:  Muscle Nerve       Date:  1989-10       Impact factor: 3.217

View more
  3 in total

1.  Phospho-tyrosine phosphatase inhibitor Bpv(Hopic) enhances C2C12 myoblast migration in vitro. Requirement of PI3K/AKT and MAPK/ERK pathways.

Authors:  Georgi A Dimchev; Nasser Al-Shanti; Claire E Stewart
Journal:  J Muscle Res Cell Motil       Date:  2013-04-04       Impact factor: 2.698

2.  Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle.

Authors:  Pierre-François Lesault; Marine Theret; Mélanie Magnan; Sylvain Cuvellier; Yiming Niu; Romain K Gherardi; Jacques P Tremblay; Luc Hittinger; Bénédicte Chazaud
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

3.  The Mutual Interactions between Mesenchymal Stem Cells and Myoblasts in an Autologous Co-Culture Model.

Authors:  Agnieszka Kulesza; Anna Burdzinska; Izabela Szczepanska; Weronika Zarychta-Wisniewska; Beata Pajak; Kamil Bojarczuk; Bartosz Dybowski; Leszek Paczek
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.